NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Sunesis Pharmaceuticals Inc said the U.S. Food and Drug Administration called for more clinical evidence before considering approval for its cancer drug, sending the company's shares down 60 percent in after-market trading. The drug, vosaroxin, failed a late-stage trial in October as it did not significantly improve the overall survival…

news

Pfizer announced the expansion of its lease agreement with a subsidiary of Massachusetts Institute of Technology, creating a unified Pfizer campus in Kendall Square (KSQ). With this expansion, Pfizer has leased the full 500,000 square feet at 610 Main Street in Kendall Square. This space will continue to house the…

news

The WHO today said it will launch a new pilot campaign in India, Egypt and Uganda to combat hepatitis which affects over two million people globally through the use of unsafe injections. The Global Injection Safety Initiative, to focus on Hepatitis B and C which cause approximately 80 per cent…

news

Drug firm Wockhardt, which has been under the USFDA scanner, today said that United States health regulator has completed inspection of its Nalagarh facility in Himachal Pradesh. "The inspection of the company's manufacturing unit at ...Nalagarh, District Solan, Himachal Pradesh by United States Food and Drug Administration (USFDA) has since…

news

Perrigo Company plc today announced that it has entered into an agreement to acquire Naturwohl Pharma GmbH with its leading German dietary supplement brand, Yokebe. The brand is expected to generate approximately €30 million in full year 2015 net sales. Yokebe, the second largest dietary brand (by market share) in…

news

Genomics-based diagnostics and research services provider, MedGenome today said it has recieved $20 million Series B funding from Sequoia Capital. The investment will support MedGenome in accelerating the expansion of its portfolio of genetic tests, sequencing facilities in India and the US, and expanding its network with speciality hospitals /…

news

Amgen Inc's cholesterol fighting drug was approved by the European Commission, giving the keenly anticipated treatment a head start over a rival drug being developed by Regeneron Pharmaceuticals Inc and Sanofi SA. This is the first approval by any regulator for PCSK9 inhibitors, a new class of biologic drugs that…

news

Zeltia SA Says PharmaMar enters into an exclusive license and commercialization agreement with the pharmaceutical company TTY Biopharm to market and distribute the drug candidate APLIDIN(R) (plitidepsin) in Taiwan. * PharmaMar will receive an upfront payment, royalties and additional remunerations for regulatory milestones achieved by APLIDIN(R) (plitidepsin). * PharmaMar will…

news

* Selumetinib fails in Phase III trial for uveal melanoma * Drug continues to be tested in lung, other cancers * 2020 consensus sales forecast for selumetinib $305 mln AstraZeneca's much anticipated cancer drug pipeline suffered a modest blow on Wednesday when the experimental drug selumetinib failed to meet its…

news

A 6 mg dose of Biogen's experimental Alzheimer's disease drug significantly reduced beta amyloid plaque in the brain but failed to significantly slow mental decline, potentially tempering great enthusiasm that greeted data on two other doses of the treatment earlier this year. The 6 mg data, which showed some slowing…